Skip to main content

Vesalius Therapeutics

Cambridge, United States

Vesalius Therapeutics is focused on redefining the understanding and treatment of the diseases that drive ninety percent of human illness.

$75.0M raised
Mar 2022
Series A

Top Investors

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Vesalius Therapeutics

How much funding has Vesalius Therapeutics raised?
Vesalius Therapeutics has raised $75.0M in total funding. The most recent round was Series A. The last funding was announced in March 2022.
Who are Vesalius Therapeutics's investors?
Vesalius Therapeutics's investors include Flagship Pioneering.
Where is Vesalius Therapeutics headquartered?
Vesalius Therapeutics is headquartered in Cambridge, United States.
What does Vesalius Therapeutics do?
Vesalius Therapeutics is focused on redefining the understanding and treatment of the diseases that drive ninety percent of human illness.
What stage is Vesalius Therapeutics at?
Vesalius Therapeutics is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Vesalius Therapeutics — Funding & Investors." VCBacked, March 2, 2022, https://www.vcbacked.co/company/vesalius-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2022). Vesalius Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/vesalius-therapeutics
Wikipedia (cite web)
{{cite web |title=Vesalius Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/vesalius-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .